8-K - Rapport Therapeutics, Inc. (0002012593) (Filer)
Published . Updated .
Filed: 2026-10-20 AccNo: 0001193125-26-425647 Size: 11 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Directly affected
- RAPP Rapport Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-20 AccNo: 0001193125-26-425647 Size: 11 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 20 Oct 2026: Rapport Therapeutics (RAPP) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -0.39% | still updating |
| GLD | three days earlier | +0.80% | final price |
| GLD | five days earlier | +0.53% | final price |
| QQQ | that day | +0.14% | still updating |
| QQQ | three days earlier | +1.38% | final price |
| QQQ | five days earlier | +3.53% | final price |
| Rapport Therapeutics (RAPP) | that day | +3.61% | still updating |
| Rapport Therapeutics (RAPP) | three days earlier | +3.08% | final price |
| Rapport Therapeutics (RAPP) | five days earlier | +1.51% | final price |
| SPY | that day | +0.38% | still updating |
| SPY | three days earlier | +0.67% | final price |
| SPY | five days earlier | +1.49% | final price |
| TLT | that day | +0.69% | still updating |
| TLT | three days earlier | +0.67% | final price |
| TLT | five days earlier | -1.40% | final price |
Who is named in “8-K - Rapport Therapeutics, Inc. (0002012593) (Filer)”
Companies carried with this story
- RAPP Rapport Therapeutics
In “8-K - Rapport Therapeutics, Inc. (0002012593) (Filer),” Rapport Therapeutics (RAPP) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> RAPP
How “8-K - Rapport Therapeutics, Inc. (0002012593) (Filer)” reaches Rapport Therapeutics (RAPP)
The 20 Oct 2026 story “8-K - Rapport Therapeutics, Inc. (0002012593) (Filer)” names Rapport Therapeutics (RAPP) because of this story.
Rapport Therapeutics (RAPP) is on the page because SEC 8-K filing -> direct issuer disclosure -> RAPP
Price levels for Rapport Therapeutics (RAPP)
RAPP traded between 41.88 and 44.69 across 2 sessions. The latest close on file is 42.74.
How strong the case is around Rapport Therapeutics (RAPP)
37 out of 100Price not final
“8-K - Rapport Therapeutics, Inc. (0002012593) (Filer)” scores 37 out of 100. The score uses 1 sources, a +3.23% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.